| Financial Year |
March 31 2023 |
| Monetary Funds |
1,294,191,374.03 |
| Held-for-trading Financial Assets |
24,806,690.90 |
| Notes Receivable |
20,353,470.91 |
| Accounts Receivable |
5,268,950,277.78 |
| Advances to Suppliers |
146,169,615.73 |
| Other Receivables |
176,613,078.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,146,595,618.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
510,793,771.30 |
| Other Current Assets |
134,418,685.55 |
| Total Current Assets |
9,605,032,694.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
95,076,642.32 |
| Investment Properties |
-- |
| Fixed Assetes |
392,734,481.67 |
| Under-construction Projects |
620,014,713.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,423,521.25 |
| R&D expenses |
-- |
| Goodwill |
180,001,293.52 |
| Long-Term Deferred and Prepaid Expenses |
7,933,742.72 |
| Deferred Income Tax Assets |
102,743,692.81 |
| Other Non-Current Assets |
1,684,805,681.02 |
| Sub-Total of Non-Current Assets |
3,213,990,480.61 |
| Total Assets |
12,819,023,174.99 |
| Short-Term Loans |
2,145,505,985.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,932,903,244.03 |
| Accounts Payable |
2,158,460,808.45 |
| Accounts Received In Advance |
6,305.05 |
| Employee Compensation Payable |
86,936,999.98 |
| Taxes Payable |
418,433,396.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
63,064,930.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,658,239.31 |
| Other Current Liabilities |
14,446,279.70 |
| Sub-Total of Current Liabilities |
7,090,630,921.41 |
| Long-term Loans |
9,565,740.63 |
| Bonds Payable |
1,044,122,244.85 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
846,827.38 |
| Deferred Income Tax Liabilities |
2,702,880.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,095,530,798.22 |
| Total Liabilities |
8,186,161,719.63 |
| Paid-In Capital(Or Share Stock) |
232,590,454.00 |
| Capital Surplus |
1,781,045,608.60 |
| Surplus Reserve |
126,212,480.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,094,226,695.80 |
| Minority Stockholder's Interest |
119,877,356.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,512,984,098.44 |
| Owner's Equity（Stockholder's Equity） |
4,632,861,455.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,819,023,174.99 |
